-
-
-
-
-
-
-
The Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for Inclisiran
-
-
-
-
-
-
-
The Medicines Company Reports First-Quarter 2019 Financial Results and Significant Progress with the Inclisiran Clinical Development Program
-
-
-
-
-
-
-
The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8
-
-
-
-
-
-
-
Medicines Co. (MDCO) Highlights New Data from ORION-1 Phase II Trial at ADA 2018 Conference
-
-
-
-
-
-
-
The Medicines Company to Announce First-Quarter 2018 Financial Results on April 25
-
-
-
-
-
-
-
Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected
-
-
-
-
-
-
-
The Medicines Company Reports First-Quarter 2017 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

